Idiopathic hypereosinophilic syndrome: a case evolving in B-lymphoblastic lymphoma

Leuk Res. 2005 Aug;29(8):975-9. doi: 10.1016/j.leukres.2005.01.010. Epub 2005 Mar 2.

Abstract

Idiopathic hypereosinophilic syndrome (HES) is a rare disease characterized by tissue involvement and organ dysfunction due to abnormal eosinophil proliferation. Evolution of HES into myeloid or T-cell malignancies has been frequently reported. Here, we describe a case of HES that preceded the occurrence of a high-grade B-lymphoblastic lymphoma in which clonal evolution has been demonstrated at the molecular level.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Hypereosinophilic Syndrome / complications*
  • Hypereosinophilic Syndrome / diagnosis
  • Infant
  • Lymphoma, B-Cell / complications*
  • Lymphoma, B-Cell / diagnosis
  • Lymphoma, B-Cell / genetics
  • Oncogene Proteins, Fusion / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Remission Induction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription, Genetic

Substances

  • Oncogene Proteins, Fusion